Synthesis and Biological Evaluation of Telmisartan Alkylamine Derivatives as Potential Anticancer Agents

Tanner J Schumacher,Zachary S Gardner,Michael P McParlan,Tasmin Omy,Komaraiah Palle,Jon Rumbley,Venkatram R Mereddy,TANNER J. SCHUMACHER,ZACHARY S. GARDNER,MICHAEL P. MCPARLAN,TASMIN OMY,KOMARAIAH PALLE,JON RUMBLEY,VENKATRAM R. MEREDDY
DOI: https://doi.org/10.21873/anticanres.16885
2024-02-29
Anticancer Research
Abstract:BACKGROUND/AIM: Telmisartan is an angiotensin II receptor type 1 (AT1) antagonist with anticancer properties against solid and hematological cancer cell lines. Using telmisartan as a template, we developed alkylamine derivatives with reduced AT1 activity but increased anticancer activity.MATERIALS AND METHODS: Synthesis of candidate compounds was carried out via hexafluorophosphate benzotriazole tetramethyl uronium coupling reaction, then their inhibition of cell proliferation was determined via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and colony-formation assay was carried out on the lead candidate compound <b>8</b> Cell death via apoptosis or necrosis by compound <b>8</b> was determined by flow cytometry using annexin V and propidium iodide, tolerability dosing was carried out in ICR mice, and tumor-reduction properties were determined in an MDA-MB-231 xenograft model.RESULTS: Some of the synthesized candidates exhibited good inhibition of cell proliferation with low micromolar half maximal effective concentrations in triple-negative breast cancer cell lines MDA-MB-231 and 4T1. Compound <b>8</b> exhibited lower affinity towards AT1 than parent telmisartan, inhibition of colony formation, and cell-cycle analysis revealed apoptosis as potentially important in causing cell death. In vivo evaluation with compound <b>8</b> indicated that it was well tolerated at high concentrations in healthy mice. Additionally, compound <b>8</b> showed higher growth inhibition in the MDA-MB-231 tumor xenograft mouse model compared to telmisartan.CONCLUSION: Our study indicated that alkylamine derivatives of telmisartan exhibited good solubility and higher inhibition of cancer cell proliferation than telmisartan. Compound <b>8</b> was found to be a good lead compound, with potential for development as an anticancer agent.
oncology
What problem does this paper attempt to address?